Hypocalcemia induced by tyrosine kinase inhibitors: targeted treatment with ‘untargeted’ side effects

Authors

  • Annika M. A. Berends Department of Endocrinology, Division of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands
  • Anouk N. A. van der Horst-Schrivers Department of Endocrinology, Division of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands
  • Sjoukje F. Oosting Department of Medical Oncology, Division of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands
  • Ellen W. Kapiteijn Department of Medical Oncology, Division of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands
  • Jan Willem B. de Groot Isala Oncology Center, Zwolle, The Netherlands
  • Thera P. Links Department of Endocrinology, Division of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands

DOI:

https://doi.org/10.1080/0284186X.2020.1726455

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2020-06-02

How to Cite

Berends, A. M. A., van der Horst-Schrivers, A. N. A., Oosting, S. F., Kapiteijn, E. W., de Groot, J. W. B., & Links, T. P. (2020). Hypocalcemia induced by tyrosine kinase inhibitors: targeted treatment with ‘untargeted’ side effects. Acta Oncologica, 59(6), 726–729. https://doi.org/10.1080/0284186X.2020.1726455

Issue

Vol. 59 No. 6 (2020): Acta Oncologica

Section

Articles